Impact of E27X cdkn2a mutation on p16 and p14arf expression in melanoma families and pancreatic cancer

10543 Background: Mutations in the CDKN2A gene underlie melanoma susceptibility in as many as 50% of melanoma kindreds in selected populations, and several CDKN2A founder mutations have been descri...